Item

Fibrotic disease model with IPF hydrogels

Gamber, Bennett
Citations
Altmetric:
License
License
Abstract
Idiopathic Pulmonary Fibrosis (IPF) affects roughly 250,000 globally with a 3-5 year survival rate after being diagnosed and no cure. There is a significant gap in the knowledge surrounding cellular and molecular lung repair which in turn has delayed advancement of therapeutic approaches for IPF. The implementation of novel human lung-derived biomaterials that mimic physiological pathways in lung diseases allows us to track alveolar epithelial repopulation and repair mechanisms more effectively. Pursuing this aspect of pathophysiology provides further insight into inflammatory and interstitial pulmonary diseases and future therapeutic strategies.
Description
Date
2025-06-02
Student Status
Undergraduate
Journal Title
Journal ISSN
Volume Title
Type of presentation
Poster Presentation
Collections
UVM Student Research Conference
Show all metadata
Research Projects
Organizational Units
Journal Issue
Citation
URI
https://hdl.handle.net/20.500.14849/8997
DOI
Advisor(s)
Daniel Weiss
Department
Program/Major
Biology
College/School
College of Nursing and Health Sciences
Organization
item.page.researchcategory
Life Sciences
Embedded videos